OncohematologyOncohematologyОнкогематология1818-83462413-4023Publishing House ABV Press2010.17650/1818-8346-2013-8-3-6-15HEMATOLOGIC MALIGNANCIES: DIAGNOSIS, TREATMENT, SUPPORTIVE CAREГЕМОБЛАСТОЗЫ: ДИАГНОСТИКА, ЛЕЧЕНИЕ, СОПРОВОДИТЕЛЬНАЯ ТЕРАПИЯDevelopment of oncology: from despair to hope...Развитие онкологии. От отчаяния к надежде…ZhukovN. V.ЖуковН. В.Russian Federationzhukov.nikolay@rambler.ruRumyantsevA. G.РумянцевА. Г.Russian FederationDmitriy Rogachev Federal Research Center of Pediatric Hematology, Oncology and Immunology,
Ministry of Health of Russia
Pirogov Russian National Research Medical University, Ministry of Health of RussiaФГБУ «Федеральный научно-клинический центр детской гематологии, онкологии и иммунологии им. Дмитрия Рогачева» Минздрава России
ГБОУ ВПО «Российский национальный исследовательский медицинский университет им. Н.И. Пирогова» Минздрава России210820138361521072014210720142013https://oncohematology.abvpress.ru/ongm/article/view/20
oncologychemotherapyradiotherapysurgerytarget therapyclinical trialshistoryонкологияхимиотерапиялучевая терапияхирургияцелевая терапияклинические испытанияистория1. Virchow R. Cellular pathology as based upon physiological and pathological histology. Philadelphia: J.B. Lippincott, 1863.Virchow R. Cellular pathology as based upon physiological and pathological histology. Philadelphia: J.B. Lippincott, 1863.2. Paget S. The distribution of secondary growths in cancer of the breast. Lancet 1889;1:571–3.Paget S. The distribution of secondary growths in cancer of the breast. Lancet 1889;1:571–3.3. Rous P. A transmissible avian neoplasm (sarcoma of the common fowl). J Exp Med 1910;12:696–705.Rous P. A transmissible avian neoplasm (sarcoma of the common fowl). J Exp Med 1910;12:696–705.4. Boveri T. Zur Frage der Entwicklung maligner Tumoren. Jena, Germany: Gustav Fischer-Verlag, 1914.Boveri T. Zur Frage der Entwicklung maligner Tumoren. Jena, Germany: Gustav Fischer-Verlag, 1914.5. Warren J.C. Inhalation of ethereal vapor for the prevention of pain in surgical operations. Boston Med Surg J 1846;35:375–9.Warren J.C. Inhalation of ethereal vapor for the prevention of pain in surgical operations. Boston Med Surg J 1846;35:375–9.6. Lister J. On the antiseptic principle in the practice of surgery. Br Med J 1867;2:246–8.Lister J. On the antiseptic principle in the practice of surgery. Br Med J 1867;2:246–8.7. Whipple A.O., Parsons W.B., Mullins C.R. Treatment of carcinoma of the ampulla of Vater. Ann Surg 1935;102:763–79.Whipple A.O., Parsons W.B., Mullins C.R. Treatment of carcinoma of the ampulla of Vater. Ann Surg 1935;102:763–79.8. Halsted W.S. The results of operations for the cure of cancer of the breast performed at the Johns Hopkins Hospital from June, 1889, to January, 1894. Ann Surg 1894;20:497–555.Halsted W.S. The results of operations for the cure of cancer of the breast performed at the Johns Hopkins Hospital from June, 1889, to January, 1894. Ann Surg 1894;20:497–555.9. Roentgen K. On a new kind of rays. Stanton A, trans. Nature 1896;53:274. \Roentgen K. On a new kind of rays. Stanton A, trans. Nature 1896;53:274.10. Curie P., Curie M., Bémont G. On a new, strongly radioactive substance contained in pitchblende. CR (East Lansing, Mich) 1898;127:1215–7.Curie P., Curie M., Bémont G. On a new, strongly radioactive substance contained in pitchblende. CR (East Lansing, Mich) 1898;127:1215–7.11. Coutard H. Roentgen therapy of epitheliomas of the tonsillar region, hypopharynx, and larynx from 1920 to 1926. Am J Roentgenol 1932;28:313–31.Coutard H. Roentgen therapy of epitheliomas of the tonsillar region, hypopharynx, and larynx from 1920 to 1926. Am J Roentgenol 1932;28:313–31.12. Peters M.V. A study in survivals in Hodgkin’s disease treated radiologically. Am J Roentgenol 950;63:299–311.Peters M.V. A study in survivals in Hodgkin’s disease treated radiologically. Am J Roentgenol 950;63:299–311.13. Farber S., Diamond L.K., Mercer R.D. et al. Temporary remissions in acute leukaemia in children produced by folic acide antagonist, 4-aminopteroyl-glutamic acid (aminopterin). N Engl J Med 1948;238:787–93.Farber S., Diamond L.K., Mercer R.D. et al. Temporary remissions in acute leukaemia in children produced by folic acide antagonist, 4-aminopteroyl-glutamic acid (aminopterin). N Engl J Med 1948;238:787–93.14. Avery O.T., Macleod C.M., McCarty M. Studies of the chemical nature of the substance inducing transformation of pneumococcal types: induction of transformation by a desoxyribonucleic acid fraction isolated from pneumococcus type III. J Exp Med 1944;79:137–58.Avery O.T., Macleod C.M., McCarty M. Studies of the chemical nature of the substance inducing transformation of pneumococcal types: induction of transformation by a desoxyribonucleic acid fraction isolated from pneumococcus type III. J Exp Med 1944;79:137–58.15. Watson J.D., Crick F.H.C. Molecular structure of nucleic acids: structure for deoxyribose nucleic acid. Nature 1953;171:737–8.Watson J.D., Crick F.H.C. Molecular structure of nucleic acids: structure for deoxyribose nucleic acid. Nature 1953;171:737–8.16. Nirenberg M.W., Matthaei J.H. The dependence of cell-free protein synthesis in E. coli upon naturally occurring or synthetic polyribonucleotides. Proc Natl Acad Sci U S A 1961;47:1588–602.Nirenberg M.W., Matthaei J.H. The dependence of cell-free protein synthesis in E. coli upon naturally occurring or synthetic polyribonucleotides. Proc Natl Acad Sci U S A 1961;47:1588–602.17. Smith H.O., Wilcox K.W. A restriction enzyme from Hemophilus influenzae. I. Purification and general properties. J Mol Biol 1970;51:379–91.Smith H.O., Wilcox K.W. A restriction enzyme from Hemophilus influenzae. I. Purification and general properties. J Mol Biol 1970;51:379–91.18. Goodman L.S., Wintrobe M.M., Dameshek W. et al. Nitrogen mustard therapy: use of methyl-bis(beta-chloroethyl) amine hydrochloride and tris (beta-chloroethyl) amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia, and certain allied and miscellaneous disorders. JAMA 1946;105:475–6. 19. Frei E. III, Karon M., Levin R.H. et al. The effectiveness of combinations of antileukemic agents in inducing and maintaining remission in children with acute leukemia. Blood 1965;26:642–56.Goodman L.S., Wintrobe M.M., Dameshek W. et al. Nitrogen mustard therapy: use of methyl-bis(beta-chloroethyl) amine hydrochloride and tris (beta-chloroethyl) amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia, and certain allied and miscellaneous disorders. JAMA 1946;105:475–6. 19. Frei E. III, Karon M., Levin R.H. et al. The effectiveness of combinations of antileukemic agents in inducing and maintaining remission in children with acute leukemia. Blood 1965;26:642–56.20. DeVita V.T., Moxley J.H., Brace K., Frei E. III. Intensive combination chemotherapy and X-irradiation in the treatment of Hodgkin's disease. Proc Am Assoc Cancer Res 1965;6:15.DeVita V.T., Moxley J.H., Brace K., Frei E. III. Intensive combination chemotherapy and X-irradiation in the treatment of Hodgkin's disease. Proc Am Assoc Cancer Res 1965;6:15.21. Fisher B., Carbone P., Economou S.G. et al. L-phenylalanine mustard (L-PAM) in the management of primary breast cancer. N Engl J Med 1975;292:110–22.Fisher B., Carbone P., Economou S.G. et al. L-phenylalanine mustard (L-PAM) in the management of primary breast cancer. N Engl J Med 1975;292:110–22.22. Bonadonna G., Brusamolino E., Valagussa P. et al. Combination chemotherapy as an adjuvant treatment in operable breast cancer. N Engl J Med 1976;294:405–10.Bonadonna G., Brusamolino E., Valagussa P. et al. Combination chemotherapy as an adjuvant treatment in operable breast cancer. N Engl J Med 1976;294:405–10.23. Druker B.J., Guilhot F., O'Brien S.G. et al. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med 2006;355:2408–17.Druker B.J., Guilhot F., O'Brien S.G. et al. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med 2006;355:2408–17.24. Chapman P.B., Hauschild A., Robert C. et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 2011;364:2507–16.Chapman P.B., Hauschild A., Robert C. et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 2011;364:2507–16.25. Kwak E.L., Bang Y.-J., Camidge D.R. et al. Anaplastic lymphoma kinase inhibition in nonsmall- cell lung cancer. N Engl J Med 2010;363:1693–703.Kwak E.L., Bang Y.-J., Camidge D.R. et al. Anaplastic lymphoma kinase inhibition in nonsmall- cell lung cancer. N Engl J Med 2010;363:1693–703.26. Zhukov N.V., Tjulandin S.A. Targeted therapy in the treatment of solid tumors: practice contradicts theory. Biochemistry (Mosc) 2008;73(5):605–18.Zhukov N.V., Tjulandin S.A. Targeted therapy in the treatment of solid tumors: practice contradicts theory. Biochemistry (Mosc) 2008;73(5):605–18.27. Vasella D., Slater R. Magic Cancer Bullet: How a Tiny Orange Pill is Rewriting Medical History. New York: Harper Business, 2003.Vasella D., Slater R. Magic Cancer Bullet: How a Tiny Orange Pill is Rewriting Medical History. New York: Harper Business, 2003.28. Buzdar A., Hunt K., Buchholz T.A. et al. Improving survival of patients with breast cancer over the past 6 decades: The University of Texas M.D. Anderson Cancer Center experience. 2010 Breast Cancer Symposium: Abstract 176. Presented October 2, 2010.Buzdar A., Hunt K., Buchholz T.A. et al. Improving survival of patients with breast cancer over the past 6 decades: The University of Texas M.D. Anderson Cancer Center experience. 2010 Breast Cancer Symposium: Abstract 176. Presented October 2, 2010.29. Kohler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975;256:495–7.Kohler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975;256:495–7.30. Maloney D.G., Grillo-Lopez A.J., White C.A. et al. IDEC-C2B8 (rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma. Blood 1997;90:2188–95.Maloney D.G., Grillo-Lopez A.J., White C.A. et al. IDEC-C2B8 (rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma. Blood 1997;90:2188–95.31. Morgan D.A., Ruscetti F.W., Gallo R.G. Selective in vitro growth of T lymphocytes from normal bone marrows. Science 1976;193:1007–8.Morgan D.A., Ruscetti F.W., Gallo R.G. Selective in vitro growth of T lymphocytes from normal bone marrows. Science 1976;193:1007–8.32. Rosenberg S.A., Lotze M.T., Muul L.M. et al. Observations on the systemic administration of autologous lymphokineactivated killer cells and recombinant interleukin-2 to patients with etastatic cancer. N Engl J Med 1985;313:1485–92.Rosenberg S.A., Lotze M.T., Muul L.M. et al. Observations on the systemic administration of autologous lymphokineactivated killer cells and recombinant interleukin-2 to patients with etastatic cancer. N Engl J Med 1985;313:1485–92.33. Hodi F.S., O'Day S.J., McDermott D.F. et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010;363:711–23.Hodi F.S., O'Day S.J., McDermott D.F. et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010;363:711–23.34. Adler L. Primary malignant growth of the lungs and bronchi. London: Longmans-Green, 1912.Adler L. Primary malignant growth of the lungs and bronchi. London: Longmans-Green, 1912.35. zur Hausen H. Condylomata acuminata and human genital cancer. Cancer Res 1976;36:794.zur Hausen H. Condylomata acuminata and human genital cancer. Cancer Res 1976;36:794.36. Wong V.C., Ip H.M., Reesink H.W. et al. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin: double-blind randomised placebo-controlled study. Lancet 1984;1:921–6.Wong V.C., Ip H.M., Reesink H.W. et al. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin: double-blind randomised placebo-controlled study. Lancet 1984;1:921–6.37. Hong W.K., Lippman S.M., Itri L.M., Karp D.D. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med 1990;323:795–801.Hong W.K., Lippman S.M., Itri L.M., Karp D.D. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med 1990;323:795–801.38. Krogsbøll L.T. et al. "General health checks in adults for reducing morbidity and mortality from disease" Cochrane Database Syst Rev 2012; DOI: 10.1002/14651858.CD009009.pub2.Krogsbøll L.T. et al. "General health checks in adults for reducing morbidity and mortality from disease" Cochrane Database Syst Rev 2012; DOI: 10.1002/14651858.CD009009.pub2.39. Byers T., Barrera E., Fontham E.T. et al. A midpoint assessment of the American Cancer Society challenge goal to halve the U.S. cancer mortality rates between the years 1990 and 2015. Cancer 2006;107:396–405.Byers T., Barrera E., Fontham E.T. et al. A midpoint assessment of the American Cancer Society challenge goal to halve the U.S. cancer mortality rates between the years 1990 and 2015. Cancer 2006;107:396–405.40. Byers T.E. Trends in cancer mortality. In: DeVita V.T. Jr, Lawrence T.S., Rosenberg S.A., DePinho R.A., Weinberg R.A., eds. DeVita, Hellman, and Rosenberg's cancer: principles & practices of oncology, 9th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins, 2011. Pp. 261–268.Byers T.E. Trends in cancer mortality. In: DeVita V.T. Jr, Lawrence T.S., Rosenberg S.A., DePinho R.A., Weinberg R.A., eds. DeVita, Hellman, and Rosenberg's cancer: principles & practices of oncology, 9th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins, 2011. Pp. 261–268.41. DeVita V.T. Jr, Rosenberg S.A. Two hundred years of cancer research. N Engl J Med 2012;366:2207–14.DeVita V.T. Jr, Rosenberg S.A. Two hundred years of cancer research. N Engl J Med 2012;366:2207–14.42. Злокачественные новообразования в России в 2011 году (заболеваемость и смертность). Под ред. В.И. Чиссова, В.В. Старинского, Г.В. Петровой. М.: ФГБУ МНИОИ им. П.А. Герцена Минздрава России, 2013. 289 с.Злокачественные новообразования в России в 2011 году (заболеваемость и смертность). Под ред. В.И. Чиссова, В.В. Старинского, Г.В. Петровой. М.: ФГБУ МНИОИ им. П.А. Герцена Минздрава России, 2013. 289 с.43. Karachunskiy A., Herold R., von Stackelberg A. et al. Results of the first randomized multicentre trial on childhood acute lymphoblastic leukemia in Russia. Leukemia 2008;22(6):1144–53.Karachunskiy A., Herold R., von Stackelberg A. et al. Results of the first randomized multicentre trial on childhood acute lymphoblastic leukemia in Russia. Leukemia 2008;22(6):1144–53.44. Карачунский А.И., Румянцева Ю.В., Румянцев А.Г. Эволюция лечения острого лимфобластного лейкоза у детей: критическое использование мирового опыта в России. Вопр гематол, онкол и иммунопатол в педиатрии 2011;10(2):15–31.Карачунский А.И., Румянцева Ю.В., Румянцев А.Г. Эволюция лечения острого лимфобластного лейкоза у детей: критическое использование мирового опыта в России. Вопр гематол, онкол и иммунопатол в педиатрии 2011;10(2):15–31.